Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 63187-812
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 63187-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
This is a comparison of the side effects of cyclobenzaprine HCI tablets at different doses (5mg and 10mg) to a placebo. The side effects reported include drowsiness, dry mouth, fatigue, and headache. The percentages describe the frequency of occurrence in a test group of 464 and 249 for respective doses of the medication and 469 for placebo.*
Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
This text provides information about the side effects observed during clinical studies and a surveillance program conducted with Cyclobenzaprine HCl Tablets of 10 mg. The side effects reported include drowsiness, dry mouth, and dizziness. The percentage of patients who experienced each side effect during the clinical studies were 39%, 2%, and 1%, respectively. The percentages reported for each side effect during the surveillance program were 16%, 7%, and 3%.*
63187-812-07 (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 05)
This is a description of a medication package for Cyclobenzaprine HCI 10mg. It contains #120 tablets with a yellow, round, biconvex shape and a film coating. The tablets have "IG" on one side and "283" on the other side with the label "Cyclobenzaprine HCI 10mg". The medication is for prescription use only and was packaged by Proficent Rx LP in Thousand Oaks, CA. The product ID is PC081272 and it was manufactured by InvaGen Phammaceutiais, Inc in Hauppauge, NY 11788. The expiration date is labeled as 0010000 and it should be stored at 20°-25°C (68°-77°F). The package warns to keep the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
